What is LifePlus?
LifePlus is at the forefront of remote patient monitoring with its innovative LIFELEAF device. This non-invasive technology offers continuous, real-time tracking of critical health indicators including blood glucose, blood pressure, heart rate, and oxygen saturation, all from a single, discreet unit. By eliminating the need for consumables and patient discomfort, LifePlus aims to significantly enhance patient compliance and streamline care coordination for healthcare providers. The LIFELEAF device simplifies health data collection, enabling easier trend analysis and ultimately improving patient outcomes. The company targets both healthcare providers seeking efficient monitoring solutions and patients desiring a reliable and stylish approach to managing their health.
How much funding has LifePlus raised?
LifePlus has raised a total of $82K across 1 funding round:
Debt
$82K
Debt (2021): $82K with participation from PPP
What's next for LifePlus?
With substantial expansion capital secured, LifePlus is poised for a strategic acceleration of its growth trajectory. The company's focus on improving patient compliance and providing actionable health data to providers aligns with the increasing demand for telehealth and remote care solutions. Future investments are likely to be directed towards scaling manufacturing, expanding sales and marketing efforts to reach a broader patient and provider base, and potentially further research and development to enhance the LIFELEAF device's capabilities or expand its monitoring parameters. This funding round signifies strong investor confidence in LifePlus's business model and its potential to disrupt the patient monitoring market.
See full LifePlus company page
